Document is current
Any future updates will be listed below
-
Authors
Müller, Katharina J.
Schmidbauer, Moritz L.
Schönecker, Sonja
Kamm, Katharina
Pelz, Johann O.
Holzapfel, Korbinian
Papadopoulou, Marianna
Bakola, Eleni
Tsivgoulis, Georgios
Naumann, Markus
Hermann, Andreas
Walter, Uwe
Dimitriadis, Konstantinos
Reilich, Peter
Schöberl, Florian https://orcid.org/0000-0002-8183-8133
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DFG TRR 338, DFG TRR 274)
Bundesministerium für Bildung, Wissenschaft und Forschung
Merz Pharmaceuticals
Bristol-Myers Squibb
Canon Medical Systems USA
Daiichi Sankyo Europe
Pfizer
Thieme
Biogen
Desitin Arzneimittel
Schilling-Stiftung
Bundesministerium für Bildung und Forschung
Deutsche Gesellschaft für Muskelkranke
Alexion Pharmaceuticals
Amylyx
Alnylam Pharmaceuticals
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 9 June 2024
Revised: 11 July 2024
Accepted: 20 July 2024
First Online: 31 July 2024
Declarations
:
: KJM received financial support by Deutsche Forschungsgemeinschaft (DFG, TRR 338). MLS received financial support by Deutsche Forschungsgemeinschaft (DFG, TRR 274). UW received grants from the German Federal Ministry of Education and Research (BMBF) and Merz Pharmaceuticals, speaker honoraria from Bristol-Myers Squibb, Canon Medical Systems, Daiichi-Sankyo, Merz Pharmaceuticals, and Pfizer Pharma, and compensation from Thieme as joint Editor-in-Chief of the European Journal of Ultrasound, all outside the submitted work. AH has received personal fees and non-financial support from Biogen and Desitin during the conduct of the study outside of the submitted work. Received funding from the Schilling Stiftung für medizinische Forschung im Stifterverband, VDI/BMBF, target ALS foundation outside the submitted work. FS received financial support by Deutschen Gesellschaft für Muskelkranke (DGM) and honoraria for advisory boards of Alexion, Amylyx and Alnylam.
: Ethical approval for collecting data in the Munich cohort was obtained from the local ethics committee (protocol number 23–0833).
